Dyslipidaemia in type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone

Diabet Med. 2005 Jul:22 Suppl 3:6-10. doi: 10.1111/j.1466-5468.2005.01711c.x.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / complications*
  • Evidence-Based Medicine
  • Humans
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / etiology
  • Hypoglycemic Agents / therapeutic use*
  • Meta-Analysis as Topic
  • Pioglitazone
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone